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Epigenetic changes occur throughout life from embryonic development into adulthood.This
results in the timely expression of developmentally important genes, determining the mor-
phology and identity of different cell types and tissueswithin the body. Epigenetics regulate
gene expression and cellular morphology through multiple mechanisms without alteration
in the underlying DNA sequences. Different epigeneticmechanisms include chromatin con-
densation, post-translational modiﬁcation of histone proteins, DNA cytosinemarks, and the
activity of non-coding RNA molecules. Epigenetics play key roles in development, stem
cell differentiation, and have high impact in human disease. In this review, we will discuss
our current knowledge about these epigenetic mechanisms, with a focus on histone and
DNA marks. We will then talk about the genetics and epigenetics of embryonic stem cell
self-renewal and differentiation into neural stem cells, and further into speciﬁc neuronal
cell types.
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INTRODUCTION
Life begins upon fertilization of a haploid egg and a haploid
sperm. The resulting zygote will subsequently undergo many cel-
lular divisions in a tightly regulated manner, as part of a complex
developmental journey. The underlying genetic code remains the
same in all cells within an individual, yet an enormously diverse
population of cell types will be generated, which will constitute a
multicellular organism. By controlling gene expression, epigenetic
mechanisms instruct cellular identity and morphology, greatly
contributing to the vast assortment of cellular phenotypes (Barros
and Offenbacher, 2009; Delcuve et al., 2009; Rastegar et al., 2011).
The term “epigenetics” was used for the ﬁrst time by Wadding-
ton (1942) as a way of “genotype” controlling “phenotype” during
development. Since then, we have come a long way and the ﬁeld of
epigenetics has been revolutionized substantially. The word “epi-
genetics” is named after the Greek word, “epi” that means “on,” or
“above” the “genetics.” Epigenetics are known as inheritable pro-
gramming in gene expression that control cellular morphology
and identity, without changing the corresponding DNA sequences
(Delcuve et al., 2009; Rastegar et al., 2011). Accumulation of all
epigenetic marks deﬁne the epigenome of any given cell, similarly
in that all genetic information pertains to the genome, and protein
components to the proteome.
Epigenetics are profoundly involved in mammalian develop-
ment (Barber and Rastegar, 2010), human disease (Choo, 2011;
Zachariah and Rastegar, 2012) and embryonic stem cell (ESC) dif-
ferentiation (Delcuve et al., 2009; Rastegar et al., 2011). For the
ﬁrst time in 1981, ESCs were isolated and expanded in vitro from
the inner cell mass (ICM) of the developing mouse blastocysts
(Martin, 1981). Mouse and human ESC are pluripotent stem cells
that are capable of indeﬁnite self-renewal and differentiation into
all three germ layers (Martin, 1981; Pan and Thomson, 2007). The
discovery of these properties presented ESC as a perfect tool for
investigating early development and modeling human disease. In
addition,ESC self-renewal and differentiation properties provide a
great promise as an inexhaustible resource for cell-based therapies
in human degenerative diseases. These unique characteristics have
brought ESCs into the forefront of today’s research. ESC differ-
entiation into somatic nerve cells involves a cascade of molecular
events, and signaling pathways from the extracellular microenvi-
ronment, to the transcriptional activities within the nucleus. In
many neurological disorders, we need to direct ESCs toward spe-
ciﬁc type of neurons to be suitable for transplantation strategies
and in regenerative medicine. Such comprehensive knowledge of
gene expression proﬁles and cell fate commitment of stem cells are
essential for future stem cell-based therapy applications and for
proper in vitro modeling of neurological disorders. This informa-
tion are particularly essential for most applications in cell-based
therapy strategies and in regenerative medical approaches, where
pure populations of differentiated cell types are required for suc-
cessful transplantation. Although our scientiﬁc community has
made great advancement toward directing ESC to differentiate
into particular cell types and lineages, even with our best available
protocols, we still end up generating heterogeneous populations
of differentiated cells. The challenge of our today’s research is
therefore to understand how ESCs execute gene expression pro-
ﬁles to undergo such extensive genomic, proteomic, and epigenetic
changes during differentiation. Eventually, we would be able to
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beneﬁt from this knowledge to control the cell fate commitment
of ESCs toward any desired cell type.
In this review, we will ﬁrst describe epigenetic programming,
with a focus on chromatin structure, histone post-translational
modiﬁcations (PTM), and DNA marks. We will then discuss
ESC self-renewal and differentiation followed by the current
state of knowledge about the underlying genetics and epigenetic
mechanisms in neural development.
EPIGENETIC MECHANISMS
CHROMATIN STRUCTURE
The epigenetic information is mainly carried within the “chro-
matin” structure, referred to the combination of DNA and DNA-
bound histones (Delcuve et al., 2009; Rastegar et al., 2011). The
repetitive fundamental unit of the chromatin is termed the“nucle-
osome,” which is a combination of 146 bp of DNA molecules
wrapped around a histone octamer (Kornberg, 1974). The his-
tone octamer is composed of four nucleosomal histones, including
two of each histone H3 and histone H4 (one tetramer of H3–
2H4) and two dimers of histones H2A–H2B. Nucleosomes are
further joined by the linker DNA that is bound to the ﬁfth his-
tone, namely the linker histone H1, and can be visualized as
“beads-on-a-string” structure (Olins and Olins, 1974). At higher
level of organization, nucleosomes are assembled into a ﬁber-
like arrangement, with a diameter of 10 or 30 nm, depending on
the compaction state of the chromatin (Fussner et al., 2011a).
However, recent evidence support the idea that the 30-nm ﬁber
does not exist in vivo (Lieberman-Aiden et al., 2009), and in case
of higher order chromatin structure what actually exists is the
densely compacted 10 nm ﬁber. A chromosome is ultimately com-
prised of these “ﬁbers” and their associated proteins, which allow
the chromatin structure to condense, as can be seen throughout
cellular division. The compaction state of chromatin can be segre-
gated into tightly packed, “heterochromatin” and lightly packed
“euchromatic” regions; with the latter being accessible to gene
transcription pertaining to the expressed genome (Horvath et al.,
2001; Ellis et al., 2007; Bassett et al., 2009). As a result, the divi-
sion of chromatin into euchromatin (actively transcribed genes) is
marked by histone acetylation, and the heterochromatin (inactive
non-transcribed genes) by particular histone methylation with or
without DNAmethylation. Different heterochromatin regions are
characterizedby speciﬁc epigeneticmarks on the inactive repressed
genes (referred to as the constitutive heterochromatin) and inac-
tive silenced genes (referred to as the facultative heterochromatin).
The euchromatin and heterochromatin compartments are usu-
ally dynamic and the chromatin structure can transition between
“opened” and “closed” states by carrying a variety of chemical
groups to histone proteins or directly to the cytosine nucleotides;
in response to extrinsic factors (Delcuve et al., 2009; Rastegar et al.,
2011). In general, epigenetic marks are inheritable and can be
passed on through cellular division from the mother cells into
the daughter cells, but they are also dynamic and reversible in
response to stimuli and signaling pathways. Recently, there is an
emerging focus on the molecular mechanisms of extracellular sig-
nals translating into epigenetic changes, bringing excitement, and
introducing new concepts. This is particularly important toward
the future application of epigenetics in novel therapeutic strategies
for diseases that currently have no treatment and epigenetic dis-
orders that are caused by environmental insults. In addition to
modiﬁcation in chromatin structure, histone variants, histone
PTM, and non-coding RNAs (ncRNA) can further decrease or
inhibit gene expression, adding to the diversity of features, which
constitute the epigenome (Delcuve et al., 2009; Malecova and
Morris, 2010; Rastegar et al., 2011; Faust et al., 2012).
HISTONE VARIANTS AND POST-TRANSLATIONAL MODIFICATIONS
Each nucleosome constitutes of 146 bp of DNAwrapped around a
histone octamer, with an extra 20–50 bp stretch of DNA called the
linker region,which associates with the linker histoneH1 (Delcuve
et al., 2009). Besides histone H4, histone variants are identiﬁed for
all other histones and they can inﬂuence nuclear chromatin both
structurally and functionally (Talbert and Henikoff, 2010). These
histone variants are expressed either at the timeof DNAreplication
in S phase (H3.1 and H2A.1) or throughout the cell cycle (H2AZ
and H3.3; Mizuguchi et al., 2004; Boulard et al., 2007; Elsaesser
et al., 2010; Goldberg et al., 2010; Szenker et al., 2011). In addition
to the existence of histone variants, the epigenetic information is
further transferred throughpost-translationalmodiﬁcationof his-
tone proteins.HistonePTMinclude: acetylation,phosphorylation,
methylation, ubiquitination, sumoylation, and ADP-ribosylation
(Kouzarides, 2007; Delcuve et al., 2009). In general, histone PTM
take place on the N-terminal tail of histones, yet in limited cases,
they have been found within the core sequence of histones (Del-
cuve et al., 2009; Barber and Rastegar, 2010). Such examples are
the H3K56 acetylation (Tjeertes et al., 2009) andH3Y41 phospho-
rylation (Dawson et al., 2009), which can occur within the core of
histoneH3. The existence of the particular covalently bound small
chemical molecules on histones or DNAmolecules,will determine
the epigenetic code at any given locus. Overall, the epigenetic pro-
teins include “writer”molecules, which will deposit these covalent
marks; the “erasers” that will remove these marks; and “readers”
that interpret these marks and will intermediate or facilitate the
intended function. The cumulative action of these three types of
epigenetic proteins will eventually determine the gene accessibility
state for transcription.
Depending on the speciﬁc amino acid residues that histone
PTM are attached to, the outcome may be a tighter association
of histone proteins with DNA and repression of transcriptional
activities; or looser association, allowing transcriptional accessi-
bility of RNA polymerase and afﬁliated transcriptional machinery
(Jenuwein and Allis, 2001; Delcuve et al., 2009; Rastegar et al.,
2011). Additions of acetyl groups to the lysines 9 (K9) and 14
(K14) of histone H3 or lysine 16 of histone H4 (H4K16) are per-
formed by K-histone acetyl transferases (KAT), and correspond
with open chromatin state (Roth et al., 2001). The lysine residues
have a positive charge that leads to their tight association with
the negatively charged DNA. The addition of an acetyl group to
lysines will eliminate this positive charge leading to a more relaxed
association with DNA molecules and as a result the correspond-
ing genomic loci will become more accessible for transcription.
Removal of acetylation marks on histones is accomplished by his-
tone de-acetylases (HDAC; Zhang et al., 2002; de Ruijter et al.,
2003; Brandl et al., 2009; Delcuve et al., 2009; Rastegar et al.,
2011). Phosphorylation of histones usually occurs by addition
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of a phosphate group onto a hydroxyl group on serine (S) or
threonine (T) causing a negative charge, leading to general relax-
ation and chromatin de-condensation. A well-known example is
histone H3S10 phosphorylation that is associated with transcrip-
tional initiation in many genes (Delcuve et al., 2009). Histone
methylation is catalyzed by the activity of lysine methyl trans-
ferases (KMT), characterized by the existence of a SET domain.
Histone methylation can occur at the lysine (K) and arginine (R)
residues of histones, and depending to the degree of methylation
and the amino acid residues that become methylated, the out-
come would be different. For example, H3K4me3 is associated
with active genes, H3K9me3 is a hallmark of constitutive hete-
rochromatin and H3K27me3 marks facultative heterochromatin.
Interestingly, H3K9me2 is not associated with constitutive hete-
rochromatin, but rather it marks the silenced genes within the
facultative compartment of the heterochromatin. Using speciﬁc
antibodies raised against each of these particular histone marks,
chromatin immunoprecipitation (ChIP) techniques can be used
to identify the association of particular genomic loci with each of
these epigenetic marks. There are some histone lysine demethy-
lation (KDM) enzymes that can erase the histone methyl marks
from active or repressed genes, which would also depend on the
amino acid residues that are methylated.
In addition to these histone marks, other modiﬁcations are
found at the lysine residues such as ubiquitination, which has
been found on the histones H2A (K119) and H2B (K120; Delcuve
et al., 2009; Rastegar et al., 2011). The molecular mechanism of
histone ubiquitination is still not fully understood, but it is likely
that it functions in keeping chromatin at the open/active state due
to its large molecular size (Calvanese and Fraga, 2012). Another
identiﬁed histone PTM is the sumoylation that occurs in the core
region of the four nucleosomal histones, and it happens at the
exact same lysines that can become acetylated or ubiquitinated,
in an exclusive manner. Other histone PTM include proline iso-
merization and ADP-ribosylation, both of which are involved in
transcriptional gene regulation. It should be noted that the exis-
tence of histone marks on the same amino acids are exclusive and
they may not occur at an individual residue, simultaneously. This
is one of several forms of histone crosstalks, and here the existence
of one histone PTMwould prevent the deposition of another form
to happen at the same residue.Histone crosstalks are not limited to
the same histone molecules; rather,modiﬁcation of an amino acid
on one histone can also inﬂuence deposition of a different form of
PTMon another histonemolecule. In addition to the histone PTM
crosstalks, these covalent modiﬁcations can direct gene expres-
sion through crosstalks with chemical groups on DNA molecules
such asDNAmethylation or 5-hydroxymethylation (Delcuve et al.,
2009; Calvanese and Fraga, 2012).
DNA MARKS
In addition to methylation of lysine residues within the histone
proteins, methylation can also proceed directly on DNA mole-
cules. DNA methylation occurs on the 5′ carbon of the cytosine
nucleotides (5mC), next to guanine (CpG dinucleotides). DNA
methylation is a hallmark of transcriptionally inactive genes and
usually correlates with gene repression and silencing (Suzuki and
Bird, 2008; Delcuve et al., 2009), genomic imprinting (Li et al.,
1993), and X-chromosome inactivation (Mohandas et al., 1981).
De-regulated DNA methylation leads to human disease, mental
retardation, and neurological disorders, such as Rett Syndrome
(Warren, 2007; Jin et al., 2008; Delcuve et al., 2009). Epigenetic re-
programming of primordial germ cells is crucial for erasing inher-
ited epigenetic marks; and in the establishment of totipotency
(Reik et al., 2001). Shortly after fertilization, the male pro-nucleus
within the zygote will go through a process of genome-wide active
and passive demethylation events, followed by de novo methy-
lation (Santos et al., 2002; Delcuve et al., 2009). How cytosine
methylation exerts a gene silencing effect is contributed to a cou-
ple of scenarios. Firstly, transcription factors may have difﬁculties
in binding nearby methylated DNA, due to the structural hin-
drances associated with methylated CpG sites (Watt and Molloy,
1988; Tate and Bird, 1993). Secondly, repressor protein complexes
and methyl-CpG-binding proteins (MBD) can directly bind to
methylated cytosines, preventing transcription initiation (Hen-
drich and Bird, 1998; Wade, 2001; Zachariah and Rastegar, 2012).
Theprimary identiﬁedmemberof theMBDproteins is themethyl-
CpG-binding protein 2 (MeCP2; Meehan et al., 1992), mutations
in which lead to Rett Syndrome (Amir et al., 1999). MeCP2 is an
interesting protein, as it can bind to both methylated and non-
methylated DNA and act as either a transcriptional repressor or
an activator (Chahrour et al., 2008; Delcuve et al., 2009; Zachariah
and Rastegar, 2012). In the brain, direct association of MeCP2
with constitutive and facultative heterochromatin marks depends
on DNA methylation (Thambirajah et al., 2011), and its genomic
localization follows DNA methylation (Skene et al., 2010). While
MeCP2 is a widely expressed nuclear protein and can be found
in multiple tissues and cell types, it is particularly important in
the maturation of the central nervous system (CNS) and plays key
roles in neuronal maturation and dendrite formation (Rastegar
et al., 2009; Squillaro et al., 2012; Zachariah and Rastegar, 2012).
MeCP2 is involved in many cellular pathways, acting both as an
activator or a repressor, depending on the speciﬁc proteins with
which itmay interact (Chahrour et al., 2008). Its direct and indirect
interacting protein partners include HDAC1, HDAC2, the tran-
scriptional repressors mSin3A, and CoREST (Jones et al., 1998;
Nan et al., 1998; Ballas et al., 2005). The enzymes responsible
for 5mC are DNA methyltransferases (DNMTs), which consist of
DNMT1, acting during replication, and DNMT3a and DNMT3b
in de novo circumstances (Okano et al., 1999; Bestor, 2000; Del-
cuve et al., 2009; Zachariah and Rastegar, 2012). There are pivotal
crosstalks between 5mC and histone PTM (Fuks, 2005; Cedar
and Bergman, 2009), which for example, are evident in hete-
rochromatin with high levels of H3K9me3 equating with 5mC
(Stancheva, 2005). Also, the recruitment of HDAC to CpG sites
augments the repression of genomic loci (Dobosy and Selker,
2001). These epigenetic conjunctions are apparent throughout the
epigenome, and consequently, should be taken into consideration
when investigating the epigenetic regulation of any given gene.
First discovered and reported in phage DNA over half a cen-
tury ago (Wyatt and Cohen, 1953), the 5-hydroxymethylcytosine
(5hmC) is recognized as the“sixth base”of the genome. The 5hmC
is an epigenetic mark found directly on DNA, with speciﬁc tissue
(Nestor et al., 2012) and unique distribution pattern duringmam-
malian development (Tahiliani et al., 2009; Ruzov et al., 2011).
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Within the paternal pro-nucleus of the post-fertilized zygote, the
global loss of 5mC, coincides with genome-wide gain of 5hmC
(Ruzov et al., 2011). Through the action of TET (10–11 Translo-
cation) proteins, 5mC is converted into 5hmC (Ito et al., 2010).
Although the role of 5hmC is still not fully clear, it is reported to
have relatively higher expression in pluripotent stem cells, multi-
potent stem cells, and within the CNS (Ruzov et al., 2011). In the
cerebellum,5hmC ismore enriched in the Purkinje cells compared
to the granular cells, being reported to be at about 40% of the 5mC
marks highlighting a cell type-speciﬁc role for 5hmC (Kriaucionis
and Heintz, 2009). Nuclear proteins that bind to 5mC, such as
MeCP2 or MBD do not interact with 5hmC (Huang et al., 2010),
and the bisulﬁte sequencing technique that has been used com-
monly for the determination of DNA CpG methylation does not
discern between 5hmC and 5mC (Munzel et al., 2011). As a result,
this may reinforce a re-validation of our current knowledge about
knownmethylated sites attributed with speciﬁc genomic localities
obtained with classical bisulfate sequencing. It is recently shown
that the TET enzymes not only convert 5mC into 5hmC, but they
are also capable of further oxidization into formylcytosine (5fC)
and 5 carboxylcytosine (5caC; Ito et al., 2011). The presence of
5fC and 5caC have been seen in murine ESC (Ito et al., 2011; Pfaf-
feneder et al., 2011), however, the functional role of these novel
cytosine marks have not been fully uncovered yet.
MICRO RNA
Apart from the role of chromatin structure,histone PTMandDNA
marks, another form of epigenetic regulation involves RNA mol-
ecules that are afﬁliated with epigenetic memory (Morris, 2009).
MicroRNAs (miRNAs) are∼22 nucleotide-longNon-coding RNA
molecules that can regulate gene expression via binding to themes-
senger RNA with anti-sense sequence homology, leading to tran-
script degradation or translational inhibition, thereby adversely
impacting protein expression (Bartel, 2004). MicroRNAs are crit-
ical in the epigenetic regulation and they have been shown to
participate in the establishment of de novo DNA methylation in
murine ESC (Sinkkonen et al., 2008), with capability to modulate
chromatin structure and key histonemodiﬁers (Chuang and Jones,
2007).MicroRNAs have been elucidated to play regulatory roles in
stem cell proliferation and differentiation (Dubois-Dauphin et al.,
1991) and loss of components in the miRNA pathway, such as
Dicer, can alter these processes (Bernstein et al., 2003). It is the
coordinated pattern of DNA marks and histone modiﬁcations,
along with miRNA activities, which allows the proper differentia-
tion of fully functional cell types in the CNS, and throughout the
body.
CENTRAL NERVOUS SYSTEM DEVELOPMENT; THE ROLE OF
HOMEOBOX GENES
As embryonic development proceeds, the blastocyst will form
three main layers namely: the mesoderm, the ectoderm, and the
endoderm. It is from the ectoderm that nervous tissue arises,
through a tightly regulated process. The early embryo consists
of the neural tube, which will eventually become the brain and
the spinal cord with full development of the CNS. In each tissue
lineage, multipotent stem cells exist which have a more restricted
range of cells to become; in the nervous system, these would be
neural stem cells (NSC; Temple, 1989; Merkle and Alvarez-Buylla,
2006; Figure 1). Within the CNS, there is an emerging focus
on molecular mechanisms of extracellular signals translating into
“epigenetic” modiﬁcations. In this regard, the activities of home-
obox transcription factors exemplify the intricately coordinated
network of developmental control.
In the developing embryo, NSC sense and respond to signals
that inﬂuence anterior–posterior (AP) and dorso-ventral (DV)
axis of the CNS (Rubenstein and Beachy, 1998; Hoch et al., 2009).
During development, NSC give rise to a wide range of cell types
and neurons within the CNS along the body axis. It is fascinat-
ing how NSC can generate particular neurons in speciﬁc locations
with appropriate extensions projecting toward target tissues and
properly reaching other neurons. A major part of these instruc-
tions are dictated by the expression of a large family of genes with
a common DNA sequence called the “homeobox (HB),” a 180-
bp DNA sequence, encoding for a DNA-binding domain called
the “homeodomain” (HD). The homeodomain was discovered in
the fruit ﬂy “Drosophila Melanogaster” about three decades ago
as a highly conserved DNA-binding domain found within the
developmentally important genes (McGinnis et al., 1984). These
genes were referred to as the “homeotic genes,” currently known
as the “Hox genes” (Barber and Rastegar, 2010). Since then, many
HD-containing proteins have been characterized in mammalians
sharing a similar 60 amino acid-long DNA-binding domain. Eight
such Hox genes exist in fruit ﬂy, and 39 Hox genes are identi-
ﬁed in mammals. Hox genes are key regulators of the hindbrain
segmentation into rhombomeres (r) and the “Hox code” expres-
sion within each rhombomere instructs the cellular composition
of each individual hindbrain segment. The hindbrain, that is also
named the“rhombencephalon,” is themost posterior compartment
of the brain in a developing embryo, and anterior to that we ﬁnd
the midbrain followed by the forebrain (Tvrdik and Capecchi,
2006; Narita and Rijli, 2009). Hox genes are master regulators of
development and cellular differentiation that determine the iden-
tity of individual cells within the AP and dorso-ventral axes of the
hindbrain including segmental regulation within the CNS. Hox
genes will further dictate and direct the cellular migration, axonal
direction and the process of somatogenesis during embryogenesis
and development (Studer et al., 1996; Gavalas et al., 1997; Gaufo
et al., 2004; Oury et al., 2006; Oury and Rijli, 2007).
The action of homeobox transcription factors is mediated via
regulation of their downstream target genes. As a result,HOX pro-
teins will determine the precise time and space of any given cell
type to develop and differentiate along the AP axis of a develop-
ing embryo during embryogenesis. Hox genes will further control
the proper function of each developed organ within the body.
Such a precise action of Hox genes requires their tight control of
expression at the exact location during development and in adult-
hood. The mis-regulation of Hox genes leads to human disease
and cancer (Barber and Rastegar, 2010). HOX proteins also regu-
late the differentiation of theAP and transverse planes of the spinal
cord through a collinear expression in a temporal and spatial acti-
vation order with the genes located 3′ of each cluster expressed
earlier and more anteriorly compared to the more 5′ genes within
the same cluster. Hox gene expression in the hindbrain is con-
trolled by different factors and stimuli including retinoic acid
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FIGURE 1 | Pathway of pluripotent stem cells to neural cell
populations. Fertilization and subsequent cellular divisions create the
embryonic blastocyst, where pluripotent ESC are derived (from the
inner cell mass; ICM). Additionally, pluripotent and multipotent-like cells
can be created via transduction of various factors into differentiated
tissue, such as ﬁbroblasts. In vitro analyses of pluripotent and
multipotent neural stem cells are integral for understanding aspects of
neural differentiation. The in vivo niche of stem cells contains a
considerable diversity of biomolecules whose roles still need be
deciphered. Exposure of ESC in vitro to various growth factors in
serum free media such as ﬁbroblast growth factor 2 (FGF2) and
epithelial growth factor (EGF) allows selection of cell lines possessing a
neural fate. Neural stem cells can also be acquired from adult tissue
and expanded in vitro.
(RA), a “vitamin A”-derivative, which functions in the embryonic
anterior-posterior patterning.RA treatment has beenused to study
the transcriptional expression ofHox genes in vitro (Rastegar et al.,
2004;Kobrossy et al., 2006;Nolte et al., 2006). The response toRA is
mediated through retinoic acid response elements (RARE), which
have been identiﬁed and characterized in the regulatory elements
of many Hox genes including Hoxa1, Hoxb1, Hoxa4, Hoxb4, and
Hoxd4 (Langston and Gudas, 1992; Marshall et al., 1994; Studer
et al., 1994; Dupe et al., 1997; Gould et al., 1998; Packer et al.,
1998; Zhang et al., 2000; Huang et al., 2002; Rastegar et al., 2004;
Nolte et al., 2006). There are auto- and cross-regulatory loops
that control the transcriptional expression of Hox genes, examples
of which are characterized in the expression of the most 3′ gene
within the B cluster (Hoxb1) within the rhomobomere 4. Hoxb1
expression in r4 is controlled by a network of signaling molecules,
involving Hoxb1, Hoxb2, Hoxa1, and Hoxa2 (Tumpel et al., 2007;
Barber and Rastegar, 2010).
HOXB1 regulates the development of theVII facial nerve of the
peripheral nervous system, which derives from r4 and has a tran-
sient expression prior to the formation of r5, r6, and r7 (Trainor
and Krumlauf, 2001; Tumpel et al., 2009). Hoxb1 loss-of-function
inmice indicates a non-autonomous role forHoxb1 in facial nerve
development,delineating an essential function in controlling facial
branchiomotor neuron development at the level of r4 in the hind-
brain (Arenkiel et al., 2003). The cranial neural crest cells are highly
dynamic and generate complex derivatives such as cartilage, bone,
muscle, glands, neurons, and glia and represent a population of
stemcellswith restricted cellular commitments (Cornell andEisen,
2005; Trainor, 2005; Schlosser, 2008). Hoxb1 expressing neural
crest cells preferentially generate glial progenitors associated with
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the development of motor component of VII facial nerve com-
plex and are destined to become peripheral glial cells (Arenkiel
et al., 2003). In addition to their role in AP embryonic pattern-
ing and neurogenesis, Hox genes are also involved in different
types of human cancer such as leukemia (Slany, 2009), breast can-
cer (Duriseti et al., 2006), and brain tumors (Abdel-Fattah et al.,
2006). HOX proteins regulate the expression of their target genes
through DNA-binding with different partners, inﬂuencing their
binding activity and speciﬁcity (Huang et al., 2005; Barber and
Rastegar, 2010). The best-characterized HOX cofactors are the
proto-oncogene Pre-B cell leukemia transcription factor 1 (PBX1)
and murine ectopic integration site (MEIS); both affecting HOX
DNA-binding activity/speciﬁcity (Huang et al., 2005; Barber and
Rastegar, 2010). HOX proteins have been the subject of intensive
research studies during embryonic development (Rastegar et al.,
2004; Stern et al., 2006),ESCneurogenesis (Morey et al., 2007), and
embryonic carcinoma cell (ECC) differentiation (Rastegar et al.,
2004; Huang et al., 2005; Kobrossy et al., 2006; Nolte et al., 2006).
However, due to the redundancies, which exist between the mem-
bers of each paralog groups, our knowledge about their down-
stream target genes, besides Hox genes themselves, is currently
very limited.
PLURIPOTENT EMBRYONIC STEM CELLS
Following the unionization of an egg and a sperm, a single fertil-
ized totipotent zygote will be formed that is capable of developing
into all embryonic and extra-embryonic tissues. The resulted
zygote will subsequently divide many times toward the genera-
tion of a sphere-shaped conglomerate, known as the “blastocyst”
(Rossant and Tam, 2009). This early embryonic structure has an
outer layer called the trophoblast, which will form the placenta,
and inside resides the ICM (Rossant et al., 2003), where ESCs can
be isolated (Figure 1). ICM-derived ESCs are pluripotent with
the potential of indeﬁnite self-renewal and ability to differentiate
into any cell type and tissue within the body (Reubinoff et al.,
2000; Odorico et al., 2001; Rastegar et al., 2011). Herein lays ethi-
cal controversy in stem cell research, as harvesting cells of the ICM
will resultantly destroy the embryo; one of the reasons why alter-
native methods for acquiring pluripotent cells are eagerly being
sought recently (Takahashi and Yamanaka, 2006; Robinton and
Daley, 2012). Perhaps one of the most achievements in the ﬁeld, is
the in vitro generation of pluripotent stem cells termed “induced
pluripotent stem (iPS) cells” from ﬁbroblast cells in both mice
and humans. Shinya Yamanaka was the ﬁrst to demonstrate that
retroviral transduction of cDNA comprising the pluripotent fac-
tors, Oct4, Sox2, Klf4, and c-Myc, can transform mature, lineage
restricted somatic cells into de-differentiated cells with ESC-like
properties (Takahashi andYamanaka, 2006; Takahashi et al., 2007).
Since then, many labs have successfully generated iPS cells from
different cell types andwith different inducing techniques (Wernig
et al., 2007;Aoi et al., 2008;Okita et al., 2008; Park et al., 2008;Hotta
et al., 2009), such as the use of piggy back vectors (Woltjen et al.,
2009), recombinant proteins (Zhou et al., 2009), nanotechnol-
ogy (Ruan et al., 2011), and small chemical compounds (Huangfu
et al., 2008; Shi et al., 2008). Recently, the transcription factors,
Brn4/Pou3f4, Sox2, Klf4, c-Myc, plus E47/Tcf3, have been used
to directly induce neural stem-like multipotent stem cells from
murine ﬁbroblasts (Han et al., 2012). In general, the processes
of re-programming the nuclear transcriptome would synchronize
with transformation of the epigenome (Sasaki and Matsui, 2008;
Fussner et al., 2011b; Mattout et al., 2011). Overall, the generation
of iPS cells has brought great promise and excitement into the
translational research, regenerative medicine andmodern innova-
tive therapeutic approaches with regards to addressing the current
shortage of organs and tissues for transplantation applications.
Currently, there is an intensive effort in our scientiﬁc commu-
nity in search of perfecting the iPS cell generation and to better
develop technologies for in vivo application of iPS cells. Regard-
less, this technology has already given us an opportunity to model
human disease such as neurological disorders, with no accessible
neurons to study the mechanism of disease prior to the develop-
ment of the iPS technology. Although iPS cell research is still at
its infancy period, it has already given us hope by the success of
curing limited diseases inmousemodels, such as sickle cell anemia
in mice (Hanna et al., 2007).
Tomaintain pluripotency, ESCs continuously express key tran-
scription factors such as OCT4 and NANOG along with the SOX2
protein during their self-renewal. These proteins contribute and
share at least in part in the regulation of downstream devel-
opmentally important genes. Additionally, OCT4 controls the
expression H3K9me2/3 demethylases and as a consequence con-
tributes in maintaining the epigenetic landscape during ESC self-
renewal (Loh et al., 2007; Calvanese and Fraga, 2012). Moreover,
through the simultaneous existence of both active and inactive
histone marks (referred to as “bivalent marks,” which will be dis-
cussed later) on the speciﬁc developmentally regulated genes, they
would remain at the poised state of transcription during ESC self-
renewal. Subsequently,during differentiation, these genesmay lose
one type of marks and become active or silenced depending on
the direction of differentiation. In general, chromatin structure in
ESCs is highly dynamic (Meshorer et al., 2006) and during differ-
entiation,histonemodiﬁcations of open chromatin such as histone
H3 andH4 acetylation are reduced globally,with a general increase
in the repressive marks such as H3K9me3. This leads to more con-
densed chromatin at speciﬁc genomic loci (and corresponding
genes) for proper differentiation (Lee et al., 2004; Meshorer et al.,
2006). Chromatin condensation, in part, is controlled by linker
histone H1 with a high ratio close to 1/nucleosome in differenti-
ated cells and 0.5 in ESCs. Depletion of three histone H1 isoforms
is lethal in mice, but such ESCs (Triple histone H1 Knock Out)
with 0.25 histone H1/nucleosome, have generated perfect tools
and opportunity to study the role of chromatin compaction in
controlling speciﬁc genomic loci (Fan et al., 2005).
MULTIPOTENT NEURAL STEM CELLS
The human brain is a central part of our nervous system, with a
constitution of over one-hundred billion neurons, with an average
of 7000 connections for each neuron (Drachman, 2005). This large
number of neurons seems to be able to compensate for the loss of
activity in part of the cells in the brain. However, depending on
location,neuronal activity lossmayhave severe consequences lead-
ing to neurological disorders. In this respect, NSC have attracted
much attention because of their potential to replace neurons and
gliawhich are lost or damaged in trauma, stroke, spinal cord injury,
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FIGURE 2 | Behavior of neural stem cells (NSC) throughout forebrain
development. Early during development, NSC increase their population of
stem cells through symmetrical cell divisions. At mid-gestation, at the
“neurogenic phase,” NSC divide asymmetrically, yielding a NSC and a neuron
or neural progenitor cell and neuron. Neural progenitor cells can further divide
symmetrically to produce two neurons. During the “gliogenic phase” in late
gestation, populations of not only neurons, but astrocytes and
oligodendrocytes are created (Merkle and Alvarez-Buylla, 2006).
amyotrophic lateral sclerosis (ALS), Parkinson’s, or Alzheimer’s
disease.Altman (1962)observed and reported the incorporationof
tritiated thymidine in neural cell types within traumatized regions
of rat brains. However, it took many years, with key experimen-
tal evidence to prove to the scientiﬁc community that the adult
nervous system can produce new neurons. There is now a wider
acknowledgment that neurons are being produced from NSC not
only during embryonic development, but also in the postnatal
brain. In the developing embryo, NSC sense, and respond to sig-
nals that inﬂuence the AP and dorso-ventral axes of the CNS
(Rubenstein andBeachy,1998;Hoch et al., 2009).NSCare primary
progenitors capable of self-renewal and differentiation into the
three main cell types of the mammalian nervous system; neurons,
astrocytes, and oligodendrocytes (Namihira et al., 2008). During
the progression of nervous system development, neural stem cell
will behave differentlywhile dividing,with respect to the particular
fate commitment of their daughter cells (Hirabayashi and Gotoh,
2005). During early gestation,NSC exist as bipolar neuroepithelial
cells across the neural tube (Figure 2). At this stageNSC self-renew
and symmetrically divide into two identical daughter cells, sim-
ilar to the parental cell to increase the number of NSC. Later in
development and during mid-gestation, NSC will divide asym-
metrically, producing a new NSC and a neuron, or a neural stem
cell and a neural progenitor cell. Neural progenitor (or precursor)
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cells are intermediary between the stem cell and more differenti-
ated cells and have more limited self-renewal capability. However,
the distinction between neural precursor cells and NSC are not
always clearly deﬁned in experimental analyses, and the terms are
often used interchangeably. In later stages of embryonic develop-
ment, NSC are capable of both self-renewal and differentiation
and may give rise to neurons, astrocytes, and oligodendrocytes
(Figure 2; Qian et al., 2000).
As mentioned earlier, functional neurogenesis is not limited to
embryonic development and will continue throughout life (Ma
et al., 2010) even in the adulthood (Altman, 1962; Goldman and
Nottebohm, 1983; Eriksson et al., 1998). In the adult mammalian
brain, NSC reside in the sub granular zone of the dentate gyrus
in the hippocampus, and in the sub ventricular zone of the lateral
ventricles (Aimone et al., 2010; Gage, 2010; Bonfanti and Peretto,
2011; Lee et al., 2012). Adult neurogenesis has been shown to
be modulated by a wide range of inﬂuences from exercise (van
Praag et al., 2005; Brandt et al., 2010) and learning (Sultan et al.,
2010; Anderson et al., 2011), to pharmacological treatment with
anti-depressants (Duman et al., 2001; Anacker et al., 2011). As a
result of these observations, there is promise for discovering new
therapeutic modes of neural induction, for those who have lost
or damaged neural tissue. Since epigenetic activities are critical
for cellular differentiation (Schofer and Weipoltshammer, 2008;
Delcuve et al., 2009; Meissner, 2010), we will brieﬂy discuss the
involved molecular mechanisms with development, concerning
the transition of embryonic to NSC and mature neural cells,
including the recognition of key epigenetic activities.
EMBRYONIC STEM CELLS EMBARK ON THE NEURAL ROAD
Wehave discussed about themajor epigenetic mechanisms, neural
development, ESCs, and the role of NSC in development. We will
now focus on the metamorphoses of the epigenome that occurs
during neural commitment of ESCs; and brieﬂy address the corre-
sponding extrinsic factors, genetic transcriptional networks, and
epigenetic events (Darr andBenvenisty,2006;Ng andSurani, 2011;
Xue et al., 2011).
EXTRINSIC FACTORS ELICIT THE ACTIONS OF TRANSCRIPTIONAL
EQUIPMENT
Embryonic stem cells can be directly differentiated into specially
differentiated cell types, yet their default differentiation pathway
is into NSC (Smukler et al., 2006). In vivo, NSC are isolated from
different parts of the CNS both during embryonic development
and from the postnatal brain. Extrinsic factors that affect stem cell
differentiation include a variety of signalingmolecules and growth
factors that are critical for maintenance of ESC pluripotency and
self-renewal, or triggering differentiation (Pera and Tam, 2010). In
case of NSC, the extrinsic factors mainly originate from the cel-
lular niche, referring to the microenvironment where these cells
reside within the CNS. In NSC, the extrinsic factors tightly con-
trol the maintenance of multipotency of these cells. Important
extrinsic factors include the NOTCH Signaling family, Transform-
ing Growth Factor-β (TGF- β) superfamily members, Fibroblast
Growth Factors (FGF), Neuregulins (NRG), and Platelet Derived
Growth Factors (PDGF), to name a few (Mizutani et al., 2007; Pera
and Tam, 2010). EGF and FGF2 are known to regulate neural pro-
gramming (Reynolds and Weiss, 1996; Kuhn et al., 1997; Palmer
et al., 1999), and are used for in vitro isolation and expansion
of NSC (Gage, 2000; Reubinoff et al., 2001; Abranches et al.,
2009; Figure 1). One particular member of the EGF family, Beta-
cellulin, has been recently shown to promote cell proliferation
and drive NSC neurogenesis (Gomez-Gaviro et al., 2012). Inter-
estingly, insulin like growth factors (IGF1 and IGF2) predispose
ESCs toward a mesodermal fate (Piecewicz et al., 2012), yet IGF2
regulates adult hippocampal neurogenesis (Bracko et al., 2012).
TRANSCRIPTION FACTORS BRIDGE THE STATE OF STEM CELLS
During ESC self-renewal, key transcription factors such as OCT4,
NANOG, as well as SOX2 control ESC pluripotency via regulating
the expression of speciﬁc downstream target genes (Heng and Ng,
2010). Recently, other proteins are also shown to have similar roles
including TAF3, E-cadherin, KLF4, and PBX1 (Chan et al., 2009;
Liu et al., 2011a; Redmer et al., 2011). To point out another level of
control to these factors, the microRNA, mir-145, can target the 3′
untranslated region of Oct4, Sox2 (and Klf4) transcripts; and up-
regulation of mir-145 is evident during ESC differentiation (Xu
et al., 2009). The zinc ﬁnger nuclear protein, ZFP521, has been
recently shown to be a key regulator for driving neural differenti-
ation of ESCs; activating early neural genes in association with the
co-activator p300 (Kamiya et al., 2011). In NSC, the SOXB1 and
GLI families, CBF-1, HMGA2, HES1/5, BMI-1, HESR1/2, TLX,
MASH1, PAX6, and REST have been associated with self-renewal,
growth, and differentiation (Ahmed et al., 2009). There is ulti-
mately a cascade of epigenomic re-organization from the extrinsic
cues to the genomic machinery for modulating the stem cell state.
GENERAL CHANGES IN GENOMIC ACCESSIBILITY DURING LINEAGE
COMMITMENT
The chromatin structure in ESCs is relatively ﬂexible and dynam-
ically open with particular epigenetic signature, having a “closure”
in many regions as ESCs commit to a particular lineage (Del-
cuve et al., 2009; Rastegar et al., 2011). This is valid for genes
associated with differentiation, being “silenced” by DNA methyla-
tion and inactive histone marks in pluripotent cells compared to
multipotent stem cells (Aranda et al., 2009; Barber and Rastegar,
2010; Rastegar et al., 2011). For example, during the transition
of ESCs into the three germ layers, there is an increase in num-
ber of common DNA promoter methylation regions (CpG sites;
Delcuve et al., 2009; Isagawa et al., 2011; Rastegar et al., 2011).
Both histones (H1, H2B, H3) and non-histone chromatin pro-
teins, such as the heterochromatin protein 1 (HP1) are shown to
be loosely afﬁliated with chromatin structure in ESC, leading to a
plastic nature of pluripotent stem cells compared to more lineage
committed cells (Meshorer et al., 2006). Further, higher global
levels of histone acetylation are detected in pluripotent stem cells
in contrast to multipotent, and tissue speciﬁc stem cells as well
as somatic cell types (Efroni et al., 2008). These ﬁndings compli-
ment the observation that histone de-acetylase activity is required
for ESC differentiation (Lee et al., 2004). Pluripotent ESC also
possesses high levels of transcriptional activity, yet a large propor-
tion of gene transcripts are only expressed at low levels. Based on
a variety of global transcript analyses, it is hypothesized that as
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ESCs commit toward a speciﬁc lineage, downregulation of many
different gene transcripts increases the effectiveness of other genes
whose transcripts are not downregulated (Bibikova et al., 2008).As
a unique epigenetic characteristic of ESCs; possessing a “poised”
transcriptional state or bivalent chromatin marks are detected at
many developmentally important genomic loci such as the Hox
clusters (Bernstein et al., 2006; Delcuve et al., 2009; Barber and
Rastegar, 2010).
THE ROLE OF BIVALENT HISTONE MARKS DURING PLURIPOTENCY AND
DIFFERENTIATION
Transcriptionally actively genes in ESCs, such as Oct4 or Nanog
are characterized by histone acetylation and histone H3-Lysine 4
tri-methylation. In the other hand,most key developmental genes
remain inactive during ESC self-renewal carrying both “active”
and “inactive” histone marks. This has led to the simultaneous
detection of histone H3-lysine 27 tri-methylation and lysine 4
methylation, referring to as the category of “bivalent chromatin”
marks. Among genes with bivalent chromatin marks are the mas-
ter regulators of embryonic development, namely the members of
all four Hox clusters (Barber and Rastegar, 2010). As described
previously, HOX homeoproteins are highly conserved transcrip-
tion factors that instruct the AP axes of the developing embryo
(Rastegar et al., 2004; Huang et al., 2005; Kobrossy et al., 2006;
Nolte et al., 2006; Barber and Rastegar, 2010). The 39 mammalian
Hox genes are organized in four clusters A–D, in four different
chromosomes with unique collinear gene activation across each
chromosome (Rastegar et al., 2004; Barber and Rastegar, 2010)
along the AP axis. It has been suggested that the underlying mech-
anism is a unidirectional chromatin opening and de-condensation
along each chromosome, resulting in precise expression pattern
that is corresponding to Hox physical position within each cluster,
the phenomenonwhich is called“colinearity”(Rastegar et al., 2004;
Barber and Rastegar, 2010). We have shown such unidirectional
chromatin opening at theHoxd4 locus during embryonic develop-
ment and in differentiated P19 ECCs (Rastegar et al., 2004; Barber
and Rastegar, 2010). HOX proteins play key roles in ESCs differen-
tiation and their transcriptional expression is tightly regulated by
histone marks, chromatin condensation, other transcription fac-
tors (Chambeyron and Bickmore, 2004; Chambeyron et al., 2005;
Huang et al., 2005; Kobrossy et al., 2006; Nolte et al., 2006), and
non-coding microRNAs (Barber and Rastegar, 2010).
During differentiation of pluripotent ESCs, the “poised” state
essentially readies the stem cells for multiple descendancies; as los-
ing one of the bivalentmarks can lock a gene at a“off”or“on”state
of transcription. Perhaps the most well characterized examples of
developmentally important genes with these bivalent chromatin
marks are the Hox genes. The Polycomb Repressive Complexes
(PRC) play a role in regulating the state of ESCs (Boyer et al.,
2006) as PRC1 can compact chromatin and catalyze ubiquitina-
tion of histone H2A, whereas PRC2 can aid in compaction as
well as tri-methylation of H3K27 (Delcuve et al., 2009;Margueron
and Reinberg, 2011; Rastegar et al., 2011). PRC2 is associated at
genes necessary to preserve a pluripotent state (Lee et al., 2006),
but it has been now challenged whether the member PRC2 is
actually necessary to maintain ESC pluripotency (Chamberlain
et al., 2008). More recently, a component of PRC2, Polycomb-like
3 (Pcl3), has been shown to be instrumental for ESC self-renewal
by mediating PRC2 binding, promoting H3K27me3 formation
(Hunkapiller et al., 2012). Also, the Polycomb family repressor,
Bmi-1, is important for neural stem cell self-renewal (Molofsky
et al., 2003). Overexpression of Bmi-1 in in vitro cultures of NSC
correlates with the increased proliferation and neurogenesis; how-
ever, this was not reﬂected with the in vivo overexpression in a
transgenic murine model (He et al., 2009). The Trithorax Group
(TrxG) counteracts the Polycomb Group’s repressive effect on his-
tone bivalency (Schuettengruber et al., 2011) with tri-methylation
of H3K4 accomplished by mixed lineage leukemia (MLL) of the
Trx group (Wang et al., 2009).
Bivalent marks may become univalent during neural differen-
tiation; securing the epigenetic identity of a particular genomic
region (Delcuve et al., 2009). The MLL member, MLL1, has been
shown to be integral for resolving bivalent loci in NSC and dur-
ing neurogenesis (Lim et al., 2009). A speciﬁc demethylase of
H3K27me3, JMJD3, acts upon the promoter for Nestin, a neuro-
ﬁlament gene important in the process of neural differentiation.
This results is the activation of the Nestin gene, and a step toward
the differentiation of ESCs into NSC (Burgold et al., 2008). Fur-
thermore, the H3K4me2/3 demethylase JARID1B, is essential for
ESC commitment toward a neural lineage (Schmitz et al., 2011).
Examples of other neural genes that resolve the repressive mark of
bivalency as cells commit toward a neural lineage fate commitment
include: neurogenins (Ngns), paired box gene 6 (Pax6), SRY-Box 1
(Sox1), Sox3,Mash1 (achaete–scute complex homolog 1, orAscl1),
and NK2 transcription factor related locus 2 (Nkx2.2; Mikkelsen
et al., 2007; Hirabayashi and Gotoh, 2010). Interestingly, the DNA
mark of 5hmC, is prevalent at the promoters of “poised” regions
in self-renewing ESCs, and at the genes that are upregulated dur-
ing differentiation. Therefore, it seems that 5hmC may function
by priming regions for transcription as ESCs differentiate (Pastor
et al., 2011).
Biomolecules that can be found in nichemicroenvironments of
the developing embryo, or neurogenic regions of the adult CNS,
trigger signal transduction pathways leading to intrinsic responses
necessary for neural differentiation. Overall, as ESCs ascribe to the
neural lineage,non-neural and pluripotency-related genes become
silenced and inaccessible for transcription, whereas the promot-
ers and enhancers of neural related genes will become accessible
(Hirabayashi and Gotoh, 2010). The NSC, descendants of ESCs,
do not possess the plasticity of their parents. In the other words
they have a more constricted directional potential, and the cellular
identity of their generated daughter cells is in part impacted by the
context of the environment inwhich they reside.Many cells in their
niche such as astrocytes, neurons, endothelial cells, ependymal
cells, and immature NSC are thought to be crucial components for
NSCmaintenance and development (Duan et al., 2008). Finally, at
the last stages of the developmental journey, NSC will potentially
become specialized nerve cells; as neurons are produced during
neurogenesis and glia by the process of gliogenesis.
NEARING THE END OF THE ROAD: NEURAL DIFFERENTIATION
We have discussed a collection of factors that impact ESC and
neural stemcell fate decisions during self-perpetuation and toward
lineage differentiation. We will now brieﬂy touch-base on a
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selection of genomic machinery and miRNA that are implicated
in the processes of gliogenesis and neurogenesis; weighted more
toward players in the formation of neurons.
REST, A FACTOR FOR PREVENTING NEUROGENESIS
First discovered in 2005 (Chong et al., 1995; Schoenherr and
Anderson, 1995), the repressor element 1 (RE1) silencing tran-
scription factor (REST), also known as neuron restrictive silencing
factor (NRSF), is responsible for silencing neuronal genes in non-
neuronal tissues, neural precursor cells, ESCs, and NSC (Chen
et al., 1998; Ballas and Mandel, 2005). REST contributes to the
regulation of ESCpluripotency, and it is also involved in neural dif-
ferentiation (Soldati et al., 2012), and controlling ncRNA (Qureshi
and Mehler, 2009). The RE1 is another designation for the neu-
ron restrictive silencer element (NRSE), which is found within
many neuronal genes (Ooi and Wood, 2007). When cells commit
to a neuronal lineage, the REST complex may degrade; result-
ing in de-repression of its target genes. REST binds to the 21-bp,
RE1, and recruits HDACs as well as other chromatin modiﬁers
to silence genes. Furthermore, REST can recruit co-repressor pro-
tein complexes such as HDAC1/2, CoREST, and mSin3 (Dewald
et al., 2011). Additionally, REST has been observed to mediate the
recruitment of PRC1 and PRC2 in certain circumstances (Dietrich
et al., 2012).
MICRO RNAs TARGET NEURAL REGULATORY TRANSCRIPTS
After the discovery of their modulatory role in neural regula-
tion within the last several years (Stark et al., 2005; Krichevsky
et al., 2006),miRNAs have been under extensive investigation.One
miRNA that is prevalent within the nervous system, and particu-
larly in neuronal cells, is mir-124a (Lagos-Quintana et al., 2002).
It has shown to be critical in the process of neural differentiation
(Makeyev et al., 2007) speciﬁcally in neurogenesis, by targeting
Sox9, an important player in neural stem cell self-renewal main-
tenance (Cheng et al., 2009). Recently, in post-ischemic injured
rats, mir-124a has been shown to affect Jag1 levels, as part of the
NOTCH signaling pathway. Subsequently, the downregulation of
mir-124a induces Jag1 and proliferation of neural precursor cells,
that has been hypothesized to result from the increase of the home-
oprotein DLX2, whose corresponding transcripts are targeted by
mir-124a (Cheng et al., 2009; Liu et al., 2011b). The nuclear recep-
tor TLX, also plays key roles in neural stem cell self-renewal, and
is targeted by mir-9, resulting in increased neuronal production
through a negative regulatory feedback loop (Zhao et al., 2009).
Expression of mir-125b was similar to mir-124a in that they both
increase percentage of differentiated neuroblastoma cells (SH-
SY5Y) with neurite outgrowth. Also and some gene targets of
the mir-125b have been connected with the negative control of
neuronal related genes (Le et al., 2009).
THE LINK BETWEEN miRNA AND REST
Multiple microRNAs including, mir-9, mir-124a, and mir-132
appear to be controlled by REST (Conaco et al., 2006). For exam-
ple, mir-9 targets the REST sequence forming a negative feedback
loop (Packer et al., 2008). It has been demonstrated that mir-
124a directly targets the SCP1-3’ untranslated region of small C-
terminal domain phosphatase 1 (SCP1; Visvanathan et al., 2007).
The phosphatase, is found in non-neuronal tissues and recruited
to RE1 by REST, and has anti-neuronal function (Yeo et al., 2005).
More recently, mir-26b has been shown to represses the REST
cofactor,CTDSP2 to regulate neurogenesis (Dill et al., 2012).Addi-
tionally, MeCP2 may interact with REST to suppress particular
sites, and MeCP2 itself, is targeted by mir-132 (Klein et al., 2007).
OTHER NUCLEAR FACTORS IMPLICATED IN NEURONAL REGULATION
In the adult murine hippocampus, GADD45B, is responsible for
demethylating the promoter region of genes which are critical for
neurogenesis, such as BDNF and FGF (Ma et al., 2009). Nuclear
factor kappa B (NFκB) signaling has been observed to have novel
functionality by initiating early neurogenesis in NSC (Zhang et al.,
2012). Recently, the Querkopf (QKF), a histone acetyltransferase,
has been shown to be a useful marker of self-renewal and mul-
tipotency in NSC (Sheikh et al., 2012), and it is also essential for
normal adult neurogenesis (Merson et al., 2006).
THE FUNCTION OF STAT–p300/CBP–SMAD IN ASTROCYTE FORMATION
Astrocytic differentiation of NSC can be induced through the acti-
vation of the Janus kinase (JAK)–signal transducer and activator of
the transcription (STAT) pathway. Cytokines of the interleukin-6
(IL-6) family trigger JAK–STAT, and include the following mem-
bers; leukemia inhibitory factor (LIF), cardiotrophin-1 (CT-1),
and ciliary neurotrophic factor (CNTF; Bonni et al., 1997). The
bone morphogenic protein (BMP) family cytokine members of
the TGF-β superfamily activate SMAD transcription factors.After-
ward, a complex can be formed between STAT and SMADproteins
by the transcription co-activators, p300/CBP, which possesses
histone acetylating functionality (Nakashima et al., 1999). The
STAT–p300/CBP–SMAD complex can promote transcriptional
activation of associated genomic regions.
Moreover, the Glial ﬁbrillary acidic protein (GFAP) is an astro-
cytic marker whose promoter region is methylated during early
gestation, while it will later become demethylated.Within the pro-
moter of Gfap, there is a highly methylated CpG dinucleotide at
a STAT binding element when cells are in a neuronal phase. This
methylated CpG prevents the STAT–p300/CBP–SMAD complex
from facilitating transcriptional activation at the site (Takizawa
et al., 2001). In another astrocytic marker, S100β it is shown that
it has a methylated cytosine in its promoter region, and similarly
becomes demethylated later in gestation (Namihira et al., 2004)
much like the Gfap promoter, allowing the STAT–P300/CBP–
SMAD complex to bind and transcription to commence. MeCP2
can also bind 5mC in the exon 1 of Gfap and the CpG at the
transcriptional start sites of S100β, suppressing these astrocytic
markers and subsequent differentiation (Setoguchi et al., 2006).
APPLYING KNOWLEDGE OF THE NEURAL EPIGENOME IN
REGENERATIVE MEDICINE
There is much excitement surrounding the application of pluripo-
tent and multipotent stem cells in the hope of replenishing dam-
aged cells and tissues in various medical circumstances, such as
in neurodegenerative disease. Clinical trials are currently under-
way that involve neural stem cell transplantation in patients with
ischemic injury and ALS, with preclinical studies being imple-
mented for future cell-based treatments of brain cancer, ischemic
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spastic paraplegia, chronic spinal cord injury, and chronic stroke.
In order to attain pure populations of differentiated cell types
in vitro that can be designated for safe therapeutic use, such
as differentiated neurons or glia, a thorough comprehension of
the epigenetic mechanisms is needed. This is imperative with
induced cell types (i.e., iPS cells or induced NSC) where the
understanding of re-programmed cells is a bit further than its
infancy, as well as other in vitro cultured cell types. Nonethe-
less, patient-speciﬁc stem cells hold great promise in regenerative
medicine by supplying patients with genetically identical matches
for treatment, although heed must be taken to ensure that any
molecular variances (with epigenome, proteome, etc.), if any, do
not perturb their potential beneﬁt. Therefore, we believe that
a comprehensive mapping of the epigenome would be invalu-
able for this cause; with further investigation of novel marks
such as 5hmC, histone variants, and factors contributing to their
presence.
CONCLUSION
A selection of key epigenetic events studied in neural stem cell dif-
ferentiation have been discussed, including novel ﬁndings to date
as well as more established results in the ﬁeld. Overall, ESCs can
be described as having a dynamic increase of “closed” chromatin
marks, and decrease of “open” chromatin marks during lineage
commitment, with unique modiﬁcation patterns attributed to
lineage orientated genes. To travel further down the neural path,
a resolution of bivalent marks is required for stem cells. The dif-
ferentiation of NSC into neurons or glial cells requires regulation
of multiple miRNAs including mir-124a, mir-125b, mir-26b, and
epigeneticmodifying transcriptionalmachinery, such asGadd45b,
QKF, REST, or STAT–p300/CBP–SMAD complexes. These exam-
ples are only a few of many that demonstrate the elaborate orga-
nization of the epigenome in ESCs as they take the journey to
become neural cell types.
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